Current Context: Russia’s Federal Medical Biological Agency (FMBA) announced a colon cancer vaccine ready for use after successful preclinical trials, revealed at the 10th Eastern Economic Forum, Vladivostok.

ABOUT THE VACCINE

• Type: Therapeutic vaccine (not preventive).
• Trial Results:
  • Tumour size reduced by 60%–80%.
  • Slowed progression, improved survival rates.
  • No adverse effects, even with repeated doses.

HOW IT WORKS

• Stimulates immune system to recognize and attack tumour cells.
• Enhances recognition of tumour antigens.
• Slows disease progression and extends survival.

OTHER VACCINES IN PIPELINE

• Glioblastoma (aggressive brain cancer).
• Melanoma (including rare ocular melanoma).
• Early results show high safety and effectiveness.